Ophthalmology near Astoria, NY

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. C. Gustavo De Moraes is an Associate Professor of Clinical Ophthalmology at the Columbia University Medical Center and Attending Physician at New York Presbyterian Hospital. He sees patients with or at risk of developing glaucoma. His primary research interests are in novel techniques for glaucoma diagnosis, detection of progression, and treatment. Based on his research, Dr. De Moraes has been ranked among the top 10 glaucoma experts in the world, as cited at Expertscape.com. Dr. De Moraes completed a glaucoma fellowship at the New York Eye and Ear Infirmary (NYEEI), later directing the Glaucoma Research Unit at the Einhorn Clinical Research Center of the NYEEI. He was also a Research Associate Professor of Ophthalmology at New York University (NYU). Dr. De Moraes is a member of the American Medical Association (AMA), American College of Surgeons (ACS), American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), New York Glaucoma Society (NYGS), Ophthalmic Laser and Imaging Society (OLIS). He is past chair of the Associate Advisory Board of the World Glaucoma Association (WGA), and Education Committee of the International Council of Ophthalmology (ICO). Dr. De Moraes is the current Associate Editor for the journalInvestigative Ophthalmology and Vision Sciences (IOVS), and co-chair of Glaucoma Progression Scholas (GPS). He has published over 250 articles in peer-reviewed journals and serves as a reviewer of the editorial boards of some journals with highest impact factor in the field of Ophthalmology. He has authored/ co-authored 5 book chapters in Ophthalmology and Glaucoma, as well as the Consensus on Medical Treatment and Consensus on Glaucoma Progression of the WGA. Dr. De Moraes has twice received the American Academy of Ophthalmology (AAO) Achievement Award. His clinical research has beenfunded by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Research to Prevent Blindness (RPB). To view a full listing of Dr. DeMoraes' publications, click here.

Biography: Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models ofPde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies. He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: "Precision Medicine, CRISPR, and Genome Engineering: Movingfrom Association to Biology andTherapeutics" and "Stem Cell Biology and Regenerative Medicine in Ophthalmology", SpringerPress, NY; and "CRISPR Genome Surgery in Stem Cells and Disease Tissues", Elsevier Inc.He is an elected member of several honorary societies including the American Society forClinicalInvestigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel- Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such asScience,NEJM,Lancet,Cell Stem Cell,Nature Genetics, andJournal of Clinical Investigation, which attests to the broad impact that his work has had. Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.